These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21555920)

  • 1. Disulfide mapping reveals the domain swapping as the crucial process of the structural conversion of prion protein.
    Hafner-Bratkovič I; Jerala R
    Prion; 2011; 5(2):56-9. PubMed ID: 21555920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Globular domain of the prion protein needs to be unlocked by domain swapping to support prion protein conversion.
    Hafner-Bratkovic I; Bester R; Pristovsek P; Gaedtke L; Veranic P; Gaspersic J; Mancek-Keber M; Avbelj M; Polymenidou M; Julius C; Aguzzi A; Vorberg I; Jerala R
    J Biol Chem; 2011 Apr; 286(14):12149-56. PubMed ID: 21324909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disulfide-crosslink scanning reveals prion-induced conformational changes and prion strain-specific structures of the pathological prion protein PrP
    Taguchi Y; Lu L; Marrero-Winkens C; Otaki H; Nishida N; Schatzl HM
    J Biol Chem; 2018 Aug; 293(33):12730-12740. PubMed ID: 29934306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction of glutamines into the B2-H2 loop promotes prion protein conversion.
    Avbelj M; Hafner-Bratkovič I; Jerala R
    Biochem Biophys Res Commun; 2011 Oct; 413(4):521-6. PubMed ID: 21910969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of the human prion protein reveals a mechanism for oligomerization.
    Knaus KJ; Morillas M; Swietnicki W; Malone M; Surewicz WK; Yee VC
    Nat Struct Biol; 2001 Sep; 8(9):770-4. PubMed ID: 11524679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autocatalytic conversion of recombinant prion proteins displays a species barrier.
    Baskakov IV
    J Biol Chem; 2004 Feb; 279(9):7671-7. PubMed ID: 14668351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The charge structure of helix 1 in the prion protein regulates conversion to pathogenic PrPSc.
    Norstrom EM; Mastrianni JA
    J Virol; 2006 Sep; 80(17):8521-9. PubMed ID: 16912302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).
    Bocharova OV; Breydo L; Parfenov AS; Salnikov VV; Baskakov IV
    J Mol Biol; 2005 Feb; 346(2):645-59. PubMed ID: 15670611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seeded conversion of recombinant prion protein to a disulfide-bonded oligomer by a reduction-oxidation process.
    Lee S; Eisenberg D
    Nat Struct Biol; 2003 Sep; 10(9):725-30. PubMed ID: 12897768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversity in prion protein oligomerization pathways results from domain expansion as revealed by hydrogen/deuterium exchange and disulfide linkage.
    Eghiaian F; Daubenfeld T; Quenet Y; van Audenhaege M; Bouin AP; van der Rest G; Grosclaude J; Rezaei H
    Proc Natl Acad Sci U S A; 2007 May; 104(18):7414-9. PubMed ID: 17442756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid-liquid phase separation of full-length prion protein initiates conformational conversion in vitro.
    Tange H; Ishibashi D; Nakagaki T; Taguchi Y; Kamatari YO; Ozawa H; Nishida N
    J Biol Chem; 2021; 296():100367. PubMed ID: 33545172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrity of helix 2-helix 3 domain of the PrP protein is not mandatory for prion replication.
    Salamat K; Moudjou M; Chapuis J; Herzog L; Jaumain E; Béringue V; Rezaei H; Pastore A; Laude H; Dron M
    J Biol Chem; 2012 Jun; 287(23):18953-64. PubMed ID: 22511770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disulfide bond as a structural determinant of prion protein membrane insertion.
    Shin JY; Shin JI; Kim JS; Yang YS; Shin YK; Kim KK; Lee S; Kweon DH
    Mol Cells; 2009 Jun; 27(6):673-80. PubMed ID: 19533034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using isotopically-coded hydrogen peroxide as a surface modification reagent for the structural characterization of prion protein aggregates.
    Serpa JJ; Makepeace KA; Borchers TH; Wishart DS; Petrotchenko EV; Borchers CH
    J Proteomics; 2014 Apr; 100():160-6. PubMed ID: 24316355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein.
    Leliveld SR; Stitz L; Korth C
    Biochemistry; 2008 Jun; 47(23):6267-78. PubMed ID: 18473442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural conservation of prion strain specificities in recombinant prion protein fibrils in real-time quaking-induced conversion.
    Sano K; Atarashi R; Nishida N
    Prion; 2015; 9(4):237-43. PubMed ID: 26284507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse prion protein (PrP) segment 100 to 104 regulates conversion of PrP(C) to PrP(Sc) in prion-infected neuroblastoma cells.
    Hara H; Okemoto-Nakamura Y; Shinkai-Ouchi F; Hanada K; Yamakawa Y; Hagiwara K
    J Virol; 2012 May; 86(10):5626-36. PubMed ID: 22398286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural features of prions explored by sequence analysis. II. A PrP(Sc) model.
    Mornon JP; Prat K; Dupuis F; Boisset N; Callebaut I
    Cell Mol Life Sci; 2002 Dec; 59(12):2144-54. PubMed ID: 12568340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of rafts in the fibrillization and aggregation of prions.
    Pinheiro TJ
    Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parallel in-register intermolecular β-sheet architectures for prion-seeded prion protein (PrP) amyloids.
    Groveman BR; Dolan MA; Taubner LM; Kraus A; Wickner RB; Caughey B
    J Biol Chem; 2014 Aug; 289(35):24129-42. PubMed ID: 25028516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.